- TG Therapeutics (NASDAQ:TGTX) is scheduled to announce Q1 earnings results on Monday, May 5th, before market open.
- The consensus EPS Estimate is $0.17 (+342.9% Y/Y) and the consensus Revenue Estimate is $117.86M (+85.7% Y/Y).
- Over the last 3 months, EPS estimates
TG Therapeutics Q1 2025 Earnings Preview